Quote | Humacyte Inc Com (NASDAQ:AHAC)
Last: | $10.96 |
---|---|
Change Percent: | 7.98% |
Open: | $10.2 |
Close: | $10.96 |
High: | $11.27 |
Low: | $10.17 |
Volume: | 293,507 |
Last Trade Date Time: | 08/26/2021 04:41:32 am |
News | Humacyte Inc Com (NASDAQ:AHAC)
Humacyte raises $245M gross proceeds Combined company is expected to begin trading on the Nasdaq Global Select Market® under “HUMA” and “HUMAW” on August 27, 2021 Company well-positioned to deliver on promise of regenerative tissue HAV ...
Gainers: Good Works Acquisition (NASDAQ:GWAC) +13%. LGL Systems Acquisition (NYSE:DFNS) +7%. KE Holdings (NYSE:BEKE) +6%. Alpha Healthcare Acquisition (NASDAQ:AHAC) +6%. Losers: SelectQuote (NYSE:SLQT) -43%. Sentage Holdings (NASDAQ:SNTG) -21%. Investcorp Credit Management (NASDAQ:ICMB) -14%....
Message Board Posts | Humacyte Inc Com (NASDAQ:AHAC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Humacyte Inc Com Company Name:
AHAC Stock Symbol:
NASDAQ Market:
Humacyte raises $245M gross proceeds Combined company is expected to begin trading on the Nasdaq Global Select Market® under “HUMA” and “HUMAW” on August 27, 2021 Company well-positioned to deliver on promise of regenerative tissue HAV ...
NEW YORK and DURHAM, N.C., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination with Humacyte, I...
Appoints proven commercial leader B.J. Scheessele as Chief Commercial Officer In-house Durham, N.C. facility is operational and supplying clinical trial material produced in commercial-scale manufacturing system Company’s proprietary modular manufacturing systems ...